Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw
- PMID: 1759909
- DOI: 10.1007/BF01316742
Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw
Abstract
Five different recombinant vaccinia viruses expressing the envelope antigen of hepatitis B virus (HBsAg) under the control of the P7.5 promoter were constructed. Cell cultures infected with some of the recombinant viruses synthesized both middle (M) and major surface (S) protein of HBsAg. It was shown that the length of the nontranslated sequence preceding preS2-ATG influenced the extracellular or intracellular HBV antigen distribution and the preS2:S antigen ratio. Some recombinants synthesized an M protein that was enlarged by additional 35 amino acids of preS1 domain and was entirely retained within the infected cells. Antibody responses to the S and preS2 antigens in mice revealed significant differences in the immunogenicity of individual recombinants.
Similar articles
-
Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells.Arch Virol. 1994;134(1-2):1-15. doi: 10.1007/BF01379102. Arch Virol. 1994. PMID: 8279947
-
Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.Acta Virol. 1996 Nov-Dec;40(5-6):273-9. Acta Virol. 1996. PMID: 9171455
-
Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.World J Gastroenterol. 2005 Jan 28;11(4):492-7. doi: 10.3748/wjg.v11.i4.492. World J Gastroenterol. 2005. PMID: 15641132 Free PMC article.
-
A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.J Gen Virol. 1994 Dec;75 ( Pt 12):3673-7. doi: 10.1099/0022-1317-75-12-3673. J Gen Virol. 1994. PMID: 7527840
-
Applications of human hepatitis B virus preS domain in bio- and nanotechnology.World J Gastroenterol. 2015 Jun 28;21(24):7400-11. doi: 10.3748/wjg.v21.i24.7400. World J Gastroenterol. 2015. PMID: 26139986 Free PMC article. Review.
Cited by
-
Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells.Arch Virol. 1994;134(1-2):1-15. doi: 10.1007/BF01379102. Arch Virol. 1994. PMID: 8279947
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources